Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
- PMID: 31180516
- PMCID: PMC6580027
- DOI: 10.3892/mmr.2019.10284
Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
Abstract
Irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD) overlap. It is not clear whether GERD is caused by non‑erosive esophagitis, or erosive esophagitis. The Rome criteria are not widely used for the diagnosis of IBS in the clinic. In total, 1,489 IBS patients without red flags were included in the present retrospective study. They comprised of 1,331 females and 158 males with a mean age of 51 years. The diagnosis of IBS was verified by endoscopic and histopathological examinations. Whereas erosive esophagitis occurred in 97% of patients, only 66% had GERD symptoms. Endoscopy and histopathological examinations revealed that 1.4% of the IBS patients with diarrhea as the predominant symptom had other organic gastrointestinal diseases: 0.3% with celiac disease, 0.2% with Crohn's disease, 0.07% with ulcerative colitis, 0.6% with microscopic colitis, and 0.2% with colon cancer. Applying the Rome III criteria produced a sensitivity of 100% [95% confidence intervals (CI)=99.8‑100.0%] a specificity of 98.7% (95% CI=98.0‑99.2%), a positive likelihood ratio of 76.9%, and a negative likelihood ratio of 0%. IBS is associated with erosive esophagitis. Applying Rome III criteria without red flags and history, was effective in diagnosing IBS. Celiac disease and microscopic colitis should be considered as alternative diagnoses.
Figures





Similar articles
-
Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.Gastroenterology. 2013 Dec;145(6):1262-70.e1. doi: 10.1053/j.gastro.2013.08.048. Epub 2013 Aug 28. Gastroenterology. 2013. PMID: 23994201
-
Rome III survey of irritable bowel syndrome among ethnic Malays.World J Gastroenterol. 2012 Nov 28;18(44):6475-80; discussion p. 6479. doi: 10.3748/wjg.v18.i44.6475. World J Gastroenterol. 2012. PMID: 23197894 Free PMC article.
-
The prevalence of coeliac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.Arab J Gastroenterol. 2016 Jun;17(2):73-7. doi: 10.1016/j.ajg.2016.05.003. Epub 2016 Jun 24. Arab J Gastroenterol. 2016. PMID: 27349575
-
Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?JAMA. 2008 Oct 15;300(15):1793-805. doi: 10.1001/jama.300.15.1793. JAMA. 2008. PMID: 18854541 Review.
-
The overlap between irritable bowel syndrome and organic gastrointestinal diseases.Lancet Gastroenterol Hepatol. 2021 Feb;6(2):139-148. doi: 10.1016/S2468-1253(20)30212-0. Epub 2020 Nov 13. Lancet Gastroenterol Hepatol. 2021. PMID: 33189181 Review.
Cited by
-
Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones.Nutrients. 2019 Aug 7;11(8):1824. doi: 10.3390/nu11081824. Nutrients. 2019. PMID: 31394793 Free PMC article. Review.
-
Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome.World J Gastroenterol. 2020 Apr 7;26(13):1427-1438. doi: 10.3748/wjg.v26.i13.1427. World J Gastroenterol. 2020. PMID: 32308344 Free PMC article. Review.
-
The role of diet in the pathophysiology and management of irritable bowel syndrome.Indian J Gastroenterol. 2021 Apr;40(2):111-119. doi: 10.1007/s12664-020-01144-6. Epub 2021 Mar 5. Indian J Gastroenterol. 2021. PMID: 33666892 Free PMC article. Review.
-
Rectal Hypersensitivity in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Crohns Colitis 360. 2021 Jun 23;3(3):otab041. doi: 10.1093/crocol/otab041. eCollection 2021 Jul. Crohns Colitis 360. 2021. PMID: 36776657 Free PMC article. Review.
-
Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century.World J Gastroenterol. 2021 Jun 14;27(22):2921-2943. doi: 10.3748/wjg.v27.i22.2921. World J Gastroenterol. 2021. PMID: 34168399 Free PMC article.